Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tadalafil for Erectile Dysfunction in Cirrhosis
NCT03566914Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Jun 2018
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in erectile dysfunction (ED) comparing Tadalafil with Placebo (2 arms). Primary endpoint: Proportions of patients achieving more than a five-point gain from baseline to end point in the erectile function domain of the IIEF at 3 months. Started Jun 2018; status: completed.
02
Drugs
tadalafil
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT03566914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03566914.